z-logo
open-access-imgOpen Access
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Author(s) -
Willemien J. van Driel,
Simone N. Koole,
Karolina Sikorska,
Jules H. Schagen van Leeuwen,
Henk W.R. Schreuder,
Ralph H.M. Hermans,
Ignace H. J. T. de Hingh,
Jacobus van der Velden,
Henriëtte J.G. Arts,
Leon F.A.G. Massuger,
Arend G. J. Aalbers,
Victor J. Verwaal,
Jacobien M. Kieffer,
Koen Van de Vijver,
Harm van Tinteren,
Neil K. Aaronson,
Gabe S. Sonke
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1708618
Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , surgery , carboplatin , hazard ratio , ovarian cancer , cytoreductive surgery , chemotherapy , cisplatin , confidence interval , cancer
Treatment of newly diagnosed advanced-stage ovarian cancer typically involves cytoreductive surgery and systemic chemotherapy. We conducted a trial to investigate whether the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery would improve outcomes among patients who were receiving neoadjuvant chemotherapy for stage III epithelial ovarian cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom